Do non-ischemic cardiomyopathy patients derive superior mortality benefit from cardiac resynchronization therapy?
Larger prospective studies can substantiate this finding and better delineate which patients benefit most from CRT.
Followup of femoral condyle osteochondral allografting demonstrated durable improvement in pain and function, with graft survivorship of 82% at 10 years.